A Randomised, Multicentre, Phase II Trial of Camrelizumab with or without Metastasis-directed Stereotactic Body Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
Zhang X, Yan J, Lei Q, Neo J, Tan SH, Shu X, Huang L, Long B, Xie Y, Wang F, Wang Y, Tu H, Wang C, Zhang L, Yang J, Zhang J, Liu H, Lim DWT, Chua MLK, Sui JD, Wang Y.
Zhang X, et al. Among authors: tan sh.
Int J Radiat Oncol Biol Phys. 2024 Oct 23:S0360-3016(24)03512-0. doi: 10.1016/j.ijrobp.2024.10.019. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 39454735